 Prevention bacterial infection neutropenic patients hematologic malignancies randomized multicenter trial norfloxacin ciprofloxacin GIMEMA Infection Program Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto OBJECTIVE efficacy norfloxacin ciprofloxacin bacterial infection neutropenic patients DESIGN randomized trial SETTING Twenty-one hematologic units tertiary care university hospitals PATIENTS Eight consecutive afebrile adult patients hematologic malignancies bone marrow transplantation chemotherapy-induced neutropenia neutrophil count last days INTERVENTION Patients hours mg ciprofloxacin MEASUREMENTS Efficacy analysis patients norfloxacin ciprofloxacin MAIN RESULTS patients ciprofloxacin fever neutropenia antibiotics norfloxacin Patients ciprofloxacin rate infection infection gram-negative bacilli interval first febrile episode patients ciprofloxacin days rates infection fever unknown origin mortality compliance tolerability similar groups Patients days severe neutropenia days antifungal prophylaxis ciprofloxacin therapy CONCLUSION Ciprofloxacin development infection neutropenic patients hematologic malignancies